Rene Tarral

Title: The Innovative Contributions of Rene Tarral

Introduction

Rene Tarral is a notable inventor based in Paris, France, recognized for his significant contributions to the field of pharmaceuticals. With a total of two patents to his name, Tarral has made strides in developing advanced drug formulations that enhance therapeutic efficacy.

Latest Patents

Tarral's latest patents include innovative pharmaceutical compositions that focus on delayed-release oral dosage forms. These formulations comprise cimetidine or its salts, combined with a buffer to aid in the dissolution of cimetidine in the intestine. The coating of these dosage forms utilizes a release-delaying substance, such as Eudragit L 30 D. Another noteworthy patent involves the creation of effervescent couples, specifically histamine H2-antagonist effervescent formulations. This invention details a process for preparing a mixture of mono- and di-alkali metal citrate, which involves partially neutralizing citric acid through a reaction with an alkali metal carbonate or bicarbonate. The process is carefully controlled to manage the release of carbon dioxide during the reaction.

Career Highlights

Throughout his career, Rene Tarral has worked with esteemed organizations, including Laboratories Smith Kline & French. His work in these companies has contributed to the advancement of pharmaceutical sciences and the development of innovative drug delivery systems.

Collaborations

Tarral has collaborated with notable professionals in the field, including Jacky Mention and Graham S Leonard. These collaborations have fostered a creative environment that has led to the development of groundbreaking pharmaceutical solutions.

Conclusion

Rene Tarral's contributions to the pharmaceutical industry through his patents and collaborations highlight his innovative spirit and dedication to improving drug formulations. His work continues to influence the field and pave the way for future advancements in pharmaceutical sciences.